Department / Division:
Medicine / Endocrinology, Metabolism, and Nutrition

Address:
DUMC 3850
Durham, NC 27710

Appointment Telephone:
919-668-7630

Office Telephone:
919-668-8500

Fax Telephone:
919-668-7058

• MD, University of Virginia School of Medicine, 1993

• Internal Medicine, UNC Hospitals, 1993-1996

• Endocrinology, Metabolism and Nutrition, Duke University Medical Center, 1996-1998

Clinical Interests:
All aspects of general endocrinology including diabetes mellitus, thyroid disorders, lipid disorders, and pituitary/adrenal diseases; initiation and management of intensive insulin therapy including the use of insulin pumps

Research Interests:
Diabetes Mellitus:  Prevention strategies, predictors, treatment effects, and cardiovascular outcomes
Thyroid Disease
Bone and Calcium Disorders

Representative Publications:
Cox ME, Rowell J, Corsino L, Green JB:  Dipeptidyl Peptidase-4 Inhibitors in the Management of Type 2 Diabetes:  Safety, Tolerability, and Efficacy.  Drug, Healthcare, and Patient Safety.  2010:2, 7-19. (2010)

Pop-Busui R, Lombardero M, Lavis V, Forker A, Green J, Korytkowski M, Sobel B, Jones T (and the BARI 2D Study Group):  Relation of Severe Coronary Artery Narrowing to Insulin or Thiazolidinedione Use in Patients with Type 2 Diabetes Mellitus (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).  American Journal of Cardiology 104(1):52-58 (July, 2009). (2009)

Corsino L, Cox ME, Rowell J, Green JB:  Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes.  Clinical Medicine: Therapeutics 1:1103-1119 (August, 2009). (2009)

Bethel MA, Green JB, Califf RM, Holman RR.  Evaluating Cardiovascular Outcomes with Sitagliptin in Type 2 Diabetes:  Rationale and Design of TECOS.  Abstract presentation at the 2009 European Association for the Study of Diabetes annual meeting.

(2009)

Green JB. Disorders of monosaccharide metabolism. Garner and Klintworth’s Pathobiology of Ocular Disease, 3rd ed. GK Klintworth, A Garner (Ed.). Taylor & Francis Books; March, 2008. (2008)

Green JB, Feinglos MN: New Combination Treatments in the Management of Diabetes: Focus on Sitagliptin-Metformin.  Vascular Health and Risk Management 4(4):743-751 (August, 2008). (2008)

Brooks MM, Barsness G, Chaitman B, Chung S, Faxon D, Feit F, Frye R, Genuth S, Green J, Hlatky M, Kelsey S, Kennedy F, Krone R, Nesto R, Orchard T, O’Rourke R, Rihal C, Tardiff J (The BARI 2D Study Group):  Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial.  American Heart Journal 156(3):528-536 (September, 2008). (2008)

Green JB. Diabetes mellitus and cardiac rehabilitation in clinical practice. In Cardiac Rehabilitation, WE Kraus, SJ Keteyian (Ed.). Totowa, New Jersey: Humana; 2007:197-209. (2007)

Green JB, Feinglos MN: Update on Type 2 Diabetes:  Understanding Changes in the Diabetes Treatment  Paradigm.  International Journal of Clinical Practice 61(S154):3-11(August 2007). (2007)

Green JB. Primary Hyperparathyroidism Complicated by Extensive Skeletal Abnormalities and Severe Post-Operative Hungry Bone Syndrome.  Abstract presentation at the 2006 Endocrine Society annual meeting. (2006)

Green JB. An Unusual Cause of Severe Hypercalcemia: Adult T-Cell Lymphoma/Leukemia.  Abstract presentation at the 2006 Endocrine Society annual meeting.

(2006)

Green, JB: Visual Vignette - Vasculitis Associated with PTU Therapy. Endocrine Practice           Vol. 3 No. 4:268  (July/August 1997). (1997)